Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia

PURPOSE: A decision-analytic model was developed to study the impact of induction regimens vincristine, adriamycin, dexamethasone (VAD); thalidomide, dexamethasone (TD); and bortezomib, dexamethasone (BorD), followed by autologous stem cell transplantation (ASCT) for treating multiple myeloma (MM) p...

Descripción completa

Detalles Bibliográficos
Autores principales: Qerimi, Vjollca, Nestorovska, Aleksandra Kapedanovska, Sterjev, Zoran, Genadieva-Stavric, Sonja, Suturkova, Ljubica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016005/
https://www.ncbi.nlm.nih.gov/pubmed/29950875
http://dx.doi.org/10.2147/CEOR.S152437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016005/
https://www.ncbi.nlm.nih.gov/pubmed/29950875
http://dx.doi.org/10.2147/CEOR.S152437

Ejemplares similares